Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
UNIFI
UFI
$119M
| $2.42M | ﹤0.01% |
99,234
+972
| +1% | +$25.9K |
|
|
CYBR
2652
DELISTED
CyberArk
CYBR
| $2.42M | ﹤0.01% |
18,536
| – | – |
|
2653
Mercer International
MERC
$42.4M
| $2.41M | ﹤0.01% |
189,291
+1,431
| +0.8% | +$21.2K |
|
2654
StoneCo
STNE
$2.77B
| $2.41M | ﹤0.01% |
35,968
+11,222
| +45% | +$728K |
|
2655
El Pollo Loco
LOCO
$501M
| $2.4M | ﹤0.01% |
131,415
+2,345
| +2% | +$40.1K |
|
|
HARP
2656
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.4M | ﹤0.01% |
17,310
+1,672
| +11% | +$319K |
|
2657
Franklin Covey
FC
$242M
| $2.39M | ﹤0.01% |
73,837
+2,815
| +4% | +$86.8K |
|
2658
Bridgewater Bancshares
BWB
$571M
| $2.38M | ﹤0.01% |
147,614
-2,493
| -2% | -$41.7K |
|
|
DADA
2659
DELISTED
Dada Nexus
DADA
| $2.36M | ﹤0.01% |
81,471
+55,037
| +208% | +$1.43M |
|
|
DFTX
2660
Definium Therapeutics
DFTX
$5.77B
| $2.36M | ﹤0.01% |
+45,520
| New | +$2.39M |
|
|
TBCH
2661
Turtle Beach Corp
TBCH
$243M
| $2.35M | ﹤0.01% |
73,591
+37,383
| +103% | +$1.13M |
|
|
BDSI
2662
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.34M | ﹤0.01% |
652,885
-47,817
| -7% | -$169K |
|
2663
Acacia Research
ACTG
$427M
| $2.33M | ﹤0.01% |
344,137
+13,878
| +4% | +$82.6K |
|
2664
Cue Biopharma
CUE
$114M
| $2.33M | ﹤0.01% |
6,652
+230
| +4% | +$89.1K |
|
|
CBAY
2665
DELISTED
Cymabay Therapeutics
CBAY
| $2.32M | ﹤0.01% |
531,334
-7,780
| -1% | -$34.5K |
|
2666
Oric Pharmaceuticals
ORIC
$1.14B
| $2.31M | ﹤0.01% |
130,815
+16,312
| +14% | +$357K |
|
|
IHC
2667
DELISTED
Independence Holding Company
IHC
| $2.31M | ﹤0.01% |
49,899
+757
| +2% | +$33.6K |
|
2668
Cullinan Oncology
CGEM
$1.02B
| $2.31M | ﹤0.01% |
89,699
+3,268
| +4% | +$100K |
|
2669
MetroCity Bankshares
MCBS
$1.01B
| $2.31M | ﹤0.01% |
131,689
+4,784
| +4% | +$79.4K |
|
2670
Cato Corp
CATO
$67.9M
| $2.29M | ﹤0.01% |
135,922
-1,776
| -1% | -$26.3K |
|
2671
Instil Bio
TIL
$48.4M
| $2.29M | ﹤0.01% |
+5,922
| New | +$2.2M |
|
2672
Frontline
FRO
$8.76B
| $2.28M | ﹤0.01% |
253,207
-750
| -0.3% | -$6.04K |
|
2673
Olema Pharmaceuticals
OLMA
$999M
| $2.28M | ﹤0.01% |
81,434
+2,818
| +4% | +$80.2K |
|
|
LOTZ
2674
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $2.28M | ﹤0.01% |
417,332
+100,807
| +32% | +$636K |
|
2675
Viant Technology
DSP
$236M
| $2.28M | ﹤0.01% |
76,419
+6,633
| +10% | +$213K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.